Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-10-30

FDA Approved: MIRTAZAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for mirtazapine from Aurobindo Pharma Limited, enabling a regulatory update for this generic antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)